SP cells also demonstrated resistance to chemotherapy in Hodgkin lymphoma but, interestingly, were susceptible to elimination by novel therapies like immunotherapy [38] and NF-κB inhibition [39]. Here, NFKB1 is linked to Hodgkins lymphoma.